This week's innovation reads cover everything from the new class of drugs known as gene therapies to the newest health, wellness and medical technologies showcased at January's CES electronics extravaganza.
Several companies unveiled health, wellness and medical technology at CES 2018, a consumer technologies conference held in Las Vegas this month. CNET, a publication focused on consumer technology, compiled a list of “compelling” health technology they saw at the event. Read the roundup here.
Gene therapies gained approval in the U.S. for the first time in late 2017. The Associated Press looks at how these innovative treatments are fitting in to American medicine. Read the full piece here. (Also, read the MHCSW story on the challenge of financing these very expensive treatments for the people who need them)
During a panel, former Centers for Medicare and Medicaid Services leader Andy Slavitt and others discussed how AI may be harnessed in health care in the future. MedCity News breaks down the conversation.
The Canadian government has started using AI to analyze social media posts to try to predict suicide risk. “With that knowledge, the Canadian government could make sure more mental health resources are in the right places when needed,” according to Engadget.
Steve Betts, the CIO of Blue Cross and Blue Shield Plans in Illinois, Montana, New Mexico, Oklahoma and Texas, describes how the design thinking framework and taking a hands-on approach to innovation can help when tackling complex health care problems in a recent LinkedIn post. Read it here.